lexiara

2.

The refusal of a Community marketing authorization shall constitute a prohibition on the placing on the market of the medicinal product concerned throughout the Community.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.